• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AIRGAS THERAPEUTICS LLC ISPAN PERFLUOROPROPANE (C3F8) GAS; INTRAOCULAR GAS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AIRGAS THERAPEUTICS LLC ISPAN PERFLUOROPROPANE (C3F8) GAS; INTRAOCULAR GAS Back to Search Results
Catalog Number 8065797102
Device Problem Appropriate Term/Code Not Available (3191)
Patient Problems Cataract (1766); Conjunctivitis (1784); Vitreous Floaters (1866); Retinal Detachment (2047); Blurred Vision (2137); Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Event Date 03/30/2022
Event Type  Injury  
Manufacturer Narrative
Investigation including root cause analysis is in progress.A supplemental mdr will be filed as necessary in accordance with 21 cfr 803.56 when additional reportable information becomes available.The manufacturer internal reference number is: (b)(4).
 
Event Description
A physician reported that in the clinical trial of evaluating the safety of an ophthalmic gas during intravitreal injection a patient experienced rhegmatogenous retinal detachment, cataract development, blurred vision with dark shadow floating in their right eye, the conjunctiva of the right eye was slightly congested, ametropia and patient underwent extra scleral pressure of right eye, phacoemulsification, intraocular lens implantation, vitreous cavity injection, vitrectomy, vitreous puncture, drug injection, membrane stripping before repair of complex retinal detachment, retinal laser photocoagulation and internal pressure repair of retinal detachment (right eye).The patient was given with aminoglycoside antibiotic ointment, corticosteroids eye drops, anticholinergic eye gel, quinolone antibiotics eye drops, aminoglycoside antibiotic injection, antimuscarinic eye drops, corticosteroids suspension eye drops.The patient was generally in good condition, did not complain of discomfort, and the dressing was clean and discharged with medicine.
 
Manufacturer Narrative
Additional information was provided in sections h.6 and h.10.The perfluoropropane (c3f8) gas tank was not returned for evaluation.A review of the batch production record for lot showed no unusual manufacturing issues.A review of the complaint records showed no other complaints against the lot number.A review of confirmed complaints for patients that have experienced retinal detachment, cataracts, blurred vision, or dark shadows showed no complaints since the beginning of 2015.An analysis of the retain samples of lot numbers showed that the product was perfluoropropane (pfp) and meet all release criteria.The procedure does not comply with the directions for use (dfu).The root cause of the reported event cannot be determined.Manufacturer will continue to monitor data for evidence of adverse trending and take further action, as appropriate.The manufacturer internal reference number is: (b)(4).
 
Event Description
Additional information received clarifying the symptoms were resolved.
 
Manufacturer Narrative
Additional information was provided in section b.5.The manufacturer internal reference number is: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ISPAN PERFLUOROPROPANE (C3F8) GAS
Type of Device
INTRAOCULAR GAS
Manufacturer (Section D)
AIRGAS THERAPEUTICS LLC
6141 easton road
p.o. box 310
plumsteadville PA 18949
Manufacturer (Section G)
AIRGAS THERAPEUTICS LLC
6141 easton road
p.o. box 310
plumsteadville PA 18949
Manufacturer Contact
jonathan schlech
6201 south freeway
mail stop ab2-6
fort worth, TX 76134
8007579780
MDR Report Key14251256
MDR Text Key290391453
Report Number1610287-2022-00024
Device Sequence Number1
Product Code LPO
UDI-Device Identifier00380657971022
UDI-Public00380657971022
Combination Product (y/n)N
Reporter Country CodeCH
PMA/PMN Number
P900066
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study,Health Professional
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/15/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/29/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2023
Device Catalogue Number8065797102
Device Lot Number121407
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/24/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/17/2021
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Other;
Patient Age34 YR
Patient SexMale
Patient Weight45 KG
-
-